Annovis Bio, Inc. (ANVS) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$29.70M | -11.2% |
| 2024 | -$26.69M | +40.7% |
| 2023 | -$45.04M | -76.5% |
| 2022 | -$25.51M | -75.5% |
| 2021 | -$14.54M | -118.9% |
| 2020 | -$6.64M | -313.6% |
| 2019 | -$1.61M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$29.70M | -11.2% |
| 2024 | -$26.69M | +40.7% |
| 2023 | -$45.04M | -76.5% |
| 2022 | -$25.51M | -75.5% |
| 2021 | -$14.54M | -118.9% |
| 2020 | -$6.64M | -313.6% |
| 2019 | -$1.61M | — |